In 2021, Biogen launched Aduhelm, the first new Alzheimer's drug in decades, at a price of $56,000 per year. The FDA had approved it controversially — on shaky biomarker evidence, not clear clinical benefit. But Biogen bet big. It banked on market desperation, assumed payers would fall in line, and priced for blockbuster returns.
They misread everything.
Shortly thereafter, backlash exploded: Scientists questioned the approval, physicians refused to prescribe it, lawmakers launched investigations, CMS took the rare step of refusing broad Medicare coverage.
Biogen slashed the price nearly in half. But it was too late. Its market cap dropped by billions, investor confidence cratered, and Aduhelm became a cautionary tale in drug pricing, trial design, and regulatory miscalculation.
This wasn't just a failure of science.
It was a failure of Strategic Intelligence. Had Biogen forecasted the political blowback, payer behavior, and scientific skepticism more clearly, they might have saved the drug — or at least the damage.
In March 2025, West Virginia passed a law banning certified food dyes, despite the US FDA stating clearly that the certified food dyes are safe for use in foods. The West Virginia ban wasn't based on new toxicological breakthroughs. They were driven by public fear and pressure campaigns by activist groups that often resorted to "appeal to nature fallacies", and misinformation about the certified dyes being banned in Europe (which isn't true).
Other states are considering their own bans. This leaves companies wondering: "Do we reformulate? Will our competitors act faster? What if we pull an ingredient unnecessarily and hurt our margins, or worse, the natural substitute causes actual harm?"
The science didn't change. The politics did.
And companies without Strategic Intelligence got caught flat-footed.
This wasn’t a labeling issue.
It was a Strategic Intelligence failure -- and it's going to cost brands millions.
Detecting early signals, pressure points, and blind spots before they break into the mainstream. Anticipating competitor, regulator, and activist moves -- not reacting to them.
We use Bayesian models and Game Theory to leverage uncertainty, helping us forecast risks and timing where others only guess.
We apply methods and approaches we honed in the Intelligence Community to ensure your decisions are fast, focused, and frictionless. Our Strategic Intelligence and Comms Capabilities help you protect your position from misinformation, policy overreach, or reputational threats.
We don't just monitor competitors -- we model them. SciDiligence gives you strategic visibility into competitor pipelines, regulatory moves, and market entry timing using Bayesian modeling, AI, and real-time intelligence. We don't track what happeend last quarter -- we forecast what's coming next, and how to respond.
Policy doesn't follow the science -- it follows pressure. We track early signals across agencies, legislatures, media, and activist campaigns to model the probability of regulatory shifts, ingredient bans, and public backlash. Then we help you prepare, reposition, or respond before the rules change.
When the stakes are high and the data is noisy, you need more than reports and dashboards -- you need decision clarity. We help executive teams simulate strategic futures, quantify risk, and rehearse responses using predictive models and structured foresight. Wehther you're launching a product, pricing an asset, or defending against misinformation, we help you make the next move count.
We're not a research vendor or a glorified newsletter. We operate like your private, ethical CIA — collecting signals, infiltrating narratives, decoding competitor intent, and briefing you before the threat goes public. You don't need more reports. You need an intel team.
Markets don't move in straight lines — and neither should your decisions. We quantify risk, simulate outcomes, and model uncertainty using Bayesian logic built for real-world ambiguity. Where others waffle, you'll act with conviction.
No one can predict the future perfectly. But we can map what's plausible, run the scenarios, and help you build a strategy that holds — even when the landscape shifts. We don't forecast. We future-proof.
